Mersana Therapeutics, Inc. (MRSN) Reports Q4 Loss, Tops Revenue Estimates

Stock Information for Mersana Therapeutics Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Mersana Therapeutics Inc.

Spero Therapeutics to Report First Quarter 2025 Financial Results and Provide Business Update on Tuesday, May 13, 2025
Spero Therapeutics Appoints Esther Rajavelu as President and Chief Executive Officer
Spero Therapeutics Announces Fourth Quarter and Full Year 2024 Operating Results and Provides a Business Update
Spero Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Business Update on Thursday, March 27, 2025
UPDATE - Spero Therapeutics to Present at TD Cowen 45th Annual Health Care Conference
Spero Therapeutics to Present at TD Cowen 45th Annual Health Care Conference
Spero Therapeutics Provides Business Update and Announces Interim Leadership Changes
Spero Therapeutics Announces Third Quarter 2024 Operating Results and Provides a Business Update

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.